This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

KIK Custom Products To Acquire BioLab Consumer Products Business From Chemtura Corporation

Stocks in this article: CHMT









CONCORD, Ontario, Oct. 10, 2013 /PRNewswire/ -- KIK Custom Products Inc. ("KIK") today announced it has entered into a stock purchase agreement to acquire the Consumer Products business of Chemtura Corporation (NYSE/Euronext Paris: CHMT).  The business, which is headquartered in Lawrenceville, GA, is known as BioLab in North America and Bayrol in Europe.  The purchase price is $315 million, payable in cash, subject to customary adjustments, at closing. The acquisition is subject to customary closing conditions and regulatory approvals and is targeted to close on December 31, 2013.

"This acquisition will be an important step in the next-stage growth of our company," said Jeff Nodland, CEO, KIK. "We expect it to contribute to generating strong free cash flow while diversifying our product portfolio and expanding our customers and channels." KIK Classic Division President Stratis Katsiris added,  "The BioLab and Bayrol businesses have a history of innovation and excellent service in the markets they serve. We are excited about this acquisition, which enhances our household cleaning portfolio and furthers our ongoing commitment to pool care." KIK entered the pool care business in 2011 with the acquisition of US-based Chem-Lab Products Inc.

KIK is a portfolio company of New York-based private equity firm CI Capital Partners. The transaction will be financed through debt underwritten by Credit Suisse and UBS Investment Bank and an equity investment in KIK made by an affiliate of CI Capital Partners. 

About KIK Custom Products

With over $1.2 billion in 2012 sales and more than 3,000 employees, Toronto, Canada-based KIK is one of North America's largest contract and private label manufacturers of consumer, institutional and industrial products. The KIK network includes 14 integrated manufacturing facilities strategically located throughout North America. KIK's product lines include bleach, household cleaners and sanitizers, pool and spa water treatment products and additives, personal care, over-the-counter medicated and pharmaceutical products, all supported by in-house technical expertise and value-added services. KIK produces national brand and private label consumer products for Fortune 500 companies. For more information about KIK, visit www.kikcorp.com.

About CI Capital Partners

CI Capital Partners LLC, a North American private equity firm, has been investing in middle-market companies since 1993. CI Capital forms partnerships with experienced management teams and entrepreneurs to build substantial businesses through add-on acquisitions, organic growth and operational improvements. Since the firm's inception, CI Capital and its portfolio companies have made more than 100 acquisitions representing over $6 billion in enterprise value. CI Capital's existing portfolio consists of companies which collectively generate annual revenue of close to $4 billion, EBITDA of over $350 million and employ approximately 15,000 people. To learn more about CI Capital Partners, please visit www.cicapllc.com.

About Chemtura Corporation

Philadelphia, Pennsylvania-based Chemtura Corporation, with 2012 sales of $2.6 billion, (1) is a global manufacturer and marketer of specialty chemicals, agro chemicals, and pool, spa and home care products. Additional information concerning Chemtura is available at www.chemtura.com.

1 2012 net sales of $2.6 billion reflects discontinued operations treatment for the sale of Chemtura's Antioxidants business.

 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,678.70 +6.10 0.03%
S&P 500 2,057.09 +5.27 0.26%
NASDAQ 4,771.7630 +13.8840 0.29%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs